All Opportunities

10,543
Read more about NIC FY 2020 NIC Jail-Related Publications Revision
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

NIC FY 2020 NIC Jail-Related Publications Revision

Overview
The National Institute of Corrections (NIC) is the only federal agency with a legislative mandate (Public Law 93-415) to provide specialized services to corrections from a national perspective. In addition to other powers, such as conducting research relating to corrections, NIC has the authority to…
Discipline
Eligibility
Read more about NIC FY 2020 NIC Jail-Related Publications Revision
Read more about Telehealth in Postmenopausal Patient Care
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

Telehealth in Postmenopausal Patient Care

Overview
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG…
Amount
$100,000
Read more about Telehealth in Postmenopausal Patient Care
Read more about OSERS: Rehabilitation Services Administration (RSA): Rehabilitation Training: Innovative Rehabilitation Training Program: Field-Initiated Projects in an Area Related to Vocational Rehabilitation CFDA Number 84.263F
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

OSERS: Rehabilitation Services Administration (RSA): Rehabilitation Training: Innovative Rehabilitation Training Program: Field-Initiated Projects in an Area Related to Vocational Rehabilitation CFDA Number 84.263F

Overview
The Innovative Rehabilitation Training program is designed to develop (a) new types of training programs for rehabilitation personnel and to demonstrate the effectiveness of these new types of training programs for rehabilitation personnel in providing rehabilitation services to individuals with…
Discipline
Eligibility
Amount
$450,000
Read more about OSERS: Rehabilitation Services Administration (RSA): Rehabilitation Training: Innovative Rehabilitation Training Program: Field-Initiated Projects in an Area Related to Vocational Rehabilitation CFDA Number 84.263F
Read more about Office of Special Education and Rehabilitative Services (OSERS): Rehabilitation Services Administration (RSA): Independent Living Services for Older Individuals Who Are Blind (OIB) Program: Training and Technical Assistance CFDA Number 84.177Z
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

Office of Special Education and Rehabilitative Services (OSERS): Rehabilitation Services Administration (RSA): Independent Living Services for Older Individuals Who Are Blind (OIB) Program: Training and Technical Assistance CFDA Number 84.177Z

Overview
The purpose of this program is to provide training and technical assistance to designated State agencies (DSAs)--the State agencies that provide vocational rehabilitation services to individuals who are blind--that receive grant funding under the OIB program and to other service providers that…
Eligibility
Read more about Office of Special Education and Rehabilitative Services (OSERS): Rehabilitation Services Administration (RSA): Independent Living Services for Older Individuals Who Are Blind (OIB) Program: Training and Technical Assistance CFDA Number 84.177Z
Read more about Draft Program Description for the Open Spaces Zambia Activity
Sponsor Deadline
Posted: 4/18/2022

Draft Program Description for the Open Spaces Zambia Activity

Overview
The United States Government, represented by the U.S. Agency for International Development (USAID), is seeking input from interested applicants who may provide comments, opinions, and recommendations in response to the proposed activity approach in the subject draft program description under RFI…
Read more about Draft Program Description for the Open Spaces Zambia Activity
Read more about Request for Information – WASH Research and Learning
Sponsor Deadline
Posted: 4/18/2022

Request for Information – WASH Research and Learning

Overview
The United States Government represented by the United States Agency for International Development (USAID)’s Center for Water Security, Sanitation and Hygiene in the Bureau for Resilience and Food Security is in the process of designing a new activity or activities to answer critical implementation…
Read more about Request for Information – WASH Research and Learning
Read more about Fiscal Year 2020 Candidate Conservation Action Funds
Sponsor Deadline
Posted: 4/18/2022

Fiscal Year 2020 Candidate Conservation Action Funds

Overview
The purpose of the Endangered Species Act (ESA) is to provide a means by which the ecosystems upon which endangered and threatened species depend may be conserved, to provide a program for the conservation of such endangered species and threatened species, and to take appropriate steps to achieve…
Eligibility
Read more about Fiscal Year 2020 Candidate Conservation Action Funds
Read more about Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
Sponsor Deadline
Posted: 4/18/2022

Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)

Overview
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for support of innovative clinical and preclinical/non-clinical research to improve our understanding of disease mechanisms in tuberculosis meningitis (TBM) and to improve therapy in the presence or absence of human…
Read more about Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)
Read more about Improving Smoking Cessation Interventions among People Living with HIV (R01, R21 Clinical Trial Optional)
Sponsor Deadline
Posted: 4/18/2022

Improving Smoking Cessation Interventions among People Living with HIV (R01, R21 Clinical Trial Optional)

Overview
The purpose of this Funding Opportunity Announcement (FOA) is to provide support for research designed to optimize smoking cessation treatment among people living with HIV (PLWH) in the United States (U.S.). Responsive applications must propose research that will be conducted with PLWH and will…
Amount
$2,500,000
Read more about Improving Smoking Cessation Interventions among People Living with HIV (R01, R21 Clinical Trial Optional)
Read more about U.S. Mission to Madagascar -- Strengthening Civil Society and Local Government Engagement in Comoros
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

U.S. Mission to Madagascar -- Strengthening Civil Society and Local Government Engagement in Comoros

Overview
U.S. Embassy Antananarivo of the U.S. Department of State announces an open competition for organizations to submit applications to carry out a program to strengthen the capacity of Comorian civil society groups to work together with the government, including local elected officials such as mayors…
Amount
$100,000
Read more about U.S. Mission to Madagascar -- Strengthening Civil Society and Local Government Engagement in Comoros
Read more about Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Sponsor Deadline
Posted: 4/18/2022

Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)

Overview
NOT-AI-20-066: The purpose of this Notice is to inform the extramural community that NOT-AI-20-051, “Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19),” will expire on September 8, 2020…
Read more about Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
Read more about Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Sponsor Deadline
Posted: 4/18/2022

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Overview
This Notice of Special Interest (NOSI) highlights the urgent need to understand and address COVID-19 morbidity and mortality disparities among underserved and vulnerable populations across the United States. These two-year community-engaged Testing Research Projects will examine SARS-CoV-2 infection…
Read more about Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Read more about Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Sponsor Deadline
Posted: 4/18/2022

Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

Overview
This Notice of Special Interest (NOSI) highlights the urgent need to understand the social, ethical, and behavioral implications (SEBI) of COVID-19 testing among underserved and/or vulnerable populations across the United States through the Rapid Acceleration of Diagnostics for Underserved…
Read more about Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
Read more about Supply Chains Tracing Project
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

Supply Chains Tracing Project

Overview
The Bureau of International Labor Affairs (ILAB), U.S. Department of Labor (USDOL, or the Department), announces the availability of approximately $8,000,000 total costs (subject to the availability of federal funds) for up to two cooperative agreements of up to $4,000,000 total costs each to fund…
Read more about Supply Chains Tracing Project
Read more about Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
Sponsor Deadline
Posted: 4/18/2022

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)

Overview
The purpose of this Funding Opportunity Announcement (FOA) is to support the use of Collaborative Cross (CC) mouse lines to advance understanding of the host genetics involved in immune regulation and function and to further develop CC mouse lines that more faithfully reproduce human immune…
Read more about Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)
Read more about ADOPTION OF BIOSIMILARS IN ONCOLOGY
Sponsor Deadline
Posted: 4/18/2022

ADOPTION OF BIOSIMILARS IN ONCOLOGY

Overview
The National Comprehensive Cancer Network® (NCCN) and Pfizer Global Medical Grants (Pfizer) are collaborating to offer a new grant opportunity seeking proposals in support of the adoption of biosimilars in oncology. The intent of this RFP is to encourage NCCN Member Institutions and non-NCCN Member…
Read more about ADOPTION OF BIOSIMILARS IN ONCOLOGY
Read more about Verified Security and Performance Enhancement of Large Legacy Software (V-SPELLS)
Sponsor Deadline
Posted: 4/18/2022

Verified Security and Performance Enhancement of Large Legacy Software (V-SPELLS)

Overview
DARPA is soliciting innovative research proposals in the area of software verification and assurance by enabling piecewise, compatible-by-construction enhancement of software components in legacy United States Department of Defense (DoD) systems, and creating methods and tools to recover succinct…
Read more about Verified Security and Performance Enhancement of Large Legacy Software (V-SPELLS)
Read more about Equitable Parks and Green Spaces in Small and Midsize Cities: Planning Grant
Sponsor Deadline
Posted: 4/18/2022

Equitable Parks and Green Spaces in Small and Midsize Cities: Planning Grant

Overview
City parks and green spaces play a vital role in the social, economic, and physical well-being of America’s cities and their residents. They provide access to recreational opportunities, improve physical and mental health, spur local economies, facilitate social cohesion, improve safety, mitigate…
Read more about Equitable Parks and Green Spaces in Small and Midsize Cities: Planning Grant
Read more about Congressionally Directed Medical Research Programs (CDMRP) -- Prostate Cancer Research Program -- Prostate Cancer Pathology Resource Network Award
Sponsor Deadline
Posted: 4/18/2022
Funding Agency

Congressionally Directed Medical Research Programs (CDMRP) -- Prostate Cancer Research Program -- Prostate Cancer Pathology Resource Network Award

Overview
The FY20 PCRP Prostate Cancer Pathology Resource Network (PCPRN) Award is intended to provide infrastructure support for the development and maintenance of a prostate cancer biorepository through a collaborative network across multiple institutions that will facilitate the collection, processing…
Read more about Congressionally Directed Medical Research Programs (CDMRP) -- Prostate Cancer Research Program -- Prostate Cancer Pathology Resource Network Award
Read more about Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)
Sponsor Deadline
Posted: 4/18/2022

Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)

Overview
The purpose of this Funding Opportunity Announcement (FOA) is to support innovative studies to identify and understand the immunological responses that mediate protection from Mycobacterium tuberculosis (Mtb) infection or following vaccination with Bacillus Calmette-Guérin (BCG) or investigational…
Read more about Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)